Tag: Restorati
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restorati…...
HANGZHOU, China and SHAOXING, China, May 10, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the Investigational New Drug (IND)...